Company registration number 10189491 (England and Wales)
UBIQUICORE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
PAGES FOR FILING WITH REGISTRAR
UBIQUICORE LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
UBIQUICORE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MAY 2023
31 May 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Trade and other receivables
3
2,645
1,000
Current liabilities
4
(9,938)
(11,386)
Net current liabilities
(7,293)
(10,386)
Equity
Called up share capital
5
1,000
1,000
Retained earnings
(8,293)
(11,386)
Total equity
(7,293)
(10,386)

The director of the company has elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 8 February 2024
Mr G C De Jongh
Director
Company registration number 10189491 (England and Wales)
UBIQUICORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
- 2 -
1
Accounting policies
Company information

Ubiquicore Limited is a private company limited by shares incorporated in England and Wales. The registered office is Chantry House, 22 Upperton Road, Eastbourne, East Sussex, BN21 1BF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.5
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

UBIQUICORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
1
1
3
Trade and other receivables
2023
2022
Amounts falling due within one year:
£
£
Unpaid share capital
1,000
1,000
Amounts owed by group undertakings
1,645
-
0
2,645
1,000
4
Current liabilities
2023
2022
£
£
Bank loans and overdrafts
8,958
8,259
Other payables
20
2,407
Accruals and deferred income
960
720
9,938
11,386

The company has a bank overdraft facility of £10,000.

5
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and not fully paid
Ordinary A of £1 each
1,000
1,000
1,000
1,000
6
Related party transactions

At the year end the company was owed £1,645 from (2022: £2,387 owed to) Health Practice Associates Council CIC, a company for which it is a corporate Director and has a mutual director, Mr G De Jongh.

 

Consultancy fees of £7,112 (2022: £Nil) were paid to the director Mr G De Jongh.

 

Consultancy fees of £3,950 (2022: £2,569) were paid to Ms R De Jongh, the wife of the director Mr G De Jongh.

2023-05-312022-06-01false08 February 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityMr G C De Jonghfalse101894912022-06-012023-05-31101894912023-05-31101894912022-05-3110189491core:CurrentFinancialInstrumentscore:WithinOneYear2023-05-3110189491core:CurrentFinancialInstrumentscore:WithinOneYear2022-05-3110189491core:CurrentFinancialInstruments2023-05-3110189491core:CurrentFinancialInstruments2022-05-3110189491core:ShareCapital2023-05-3110189491core:ShareCapital2022-05-3110189491core:RetainedEarningsAccumulatedLosses2023-05-3110189491core:RetainedEarningsAccumulatedLosses2022-05-3110189491bus:Director12022-06-012023-05-31101894912021-06-012022-05-3110189491bus:PrivateLimitedCompanyLtd2022-06-012023-05-3110189491bus:SmallCompaniesRegimeForAccounts2022-06-012023-05-3110189491bus:FRS1022022-06-012023-05-3110189491bus:AuditExemptWithAccountantsReport2022-06-012023-05-3110189491bus:FullAccounts2022-06-012023-05-31xbrli:purexbrli:sharesiso4217:GBP